Cargando…
SUZ12 is a novel putative oncogene promoting tumorigenesis in head and neck squamous cell carcinoma
The suppressor of zest 12 (SUZ12), one of the core polycomb repressive complex 2 (PRC2) components, has increasingly appreciated as a key mediator during human tumorigenesis. However, its expression pattern and oncogenic roles in head and neck squamous cell carcinoma (HNSCC) remain largely unexplore...
Autores principales: | Wu, Yaping, Hu, Huijun, Zhang, Wei, Li, Zhongwu, Diao, Pengfei, Wang, Dongmiao, Wang, Yanling, Yang, Jianrong, Cheng, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010759/ https://www.ncbi.nlm.nih.gov/pubmed/29667751 http://dx.doi.org/10.1111/jcmm.13638 |
Ejemplares similares
-
Therapeutic Targeting of BRD4 in Head Neck Squamous Cell Carcinoma
por: Wu, Yaping, et al.
Publicado: (2019) -
The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma
por: Li, Jin, et al.
Publicado: (2019) -
Therapeutically targeting head and neck squamous cell carcinoma through synergistic inhibition of LSD1 and JMJD3 by TCP and GSK-J1
por: Zhang, Wei, et al.
Publicado: (2019) -
Overexpression of ZEB2‐AS1 promotes epithelial‐to‐mesenchymal transition and metastasis by stabilizing ZEB2 mRNA in head neck squamous cell carcinoma
por: Diao, Pengfei, et al.
Publicado: (2019) -
Restoration of TET2 deficiency inhibits tumor growth in head neck squamous cell carcinoma
por: Huang, Rong, et al.
Publicado: (2020)